Furthermore, HTLs induce potent humoral and cellular responses by promoting the optimal expansion of CD8 + T cells and effective maintenance of CD8 + T cells [128]; hence, a clinical trial proposed that the CD4 + T-cell population is a potential vaccine candidate for eliciting robust immune responses against HIV infection [129]. This evidence concerns the gene CD4 and HIV infectious disease.